Use of synthetic oxygen carriers to facilitate oxygen delivery
AssigneeAlliance Pharmaceutical Corp.
InventorsDuane J. Roth, Peter E. Keipert, Nicholas S. Faithfull, Thomas F. Zuck, Jean G. Riess
Life of this patent
Estimating the term…
Loading patent…
AssigneeAlliance Pharmaceutical Corp.
InventorsDuane J. Roth, Peter E. Keipert, Nicholas S. Faithfull, Thomas F. Zuck, Jean G. Riess
Estimating the term…
A method for facilitating autologous blood use by a patient facing a loss of blood, comprising the steps of removing and preferably storing a portion of the patient's blood, intravenously administering a biocompatible liquid in sufficient quantity to substantially maintain the patient's hemodynamic stability, wherein the liquid comprises an effective oxygen-delivery enhancing amount of a biocompatible synthetic oxygen carrier, after which the patient undergoes a loss of blood, and then readministering blood to the patient, preferably the stored blood. In one embodiment, the biocompatible liquid further comprises a hemodiluent and the hemodiluent is administered separately from the oxygen carrier.
A method for facilitating autologous blood use by a patient facing a loss of blood, comprising the steps of:
A method for facilitating autologous blood use by a patient facing a loss of blood during surgery, comprising the steps of:
Dependencies are inferred from the claim text.